Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients

Authors: Marek Kowalczyk, Marcin Orłowski, Piotr Siermontowski, Dariusz Mucha, Krzysztof Zinkiewicz, Waldemar Kurpiewski, Ewa Zieliński, Iwona Kowalczyk, Agnieszka Pedrycz

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Aberrant crypt foci (ACF) are commonly considered the early pre-cancerous lesions that can progress to colorectal cancer (CRC). The available literature data reveal that age, dietary factors and lifestyle can affect the development of several dozen percentages of malignant tumours, including CRC. In the present study, an attempt was made to assess the incidence and growth dynamics of ACF and to determine whether the type of diet affected the development and number of AFC.

Methods

Colonoscopy combined with rectal mucosa staining with 0.25% methylene blue was performed in 131 patients. On the day of examination, each patient completed a questionnaire regarding epidemiological data. According to their numbers, colorectal ACF were divided into three groups. The findings were analysed statistically. The Student’s t test and the U test were applied in order to determine the significance of differences of means and frequency of events in both groups. Statistica 7.1 and Excel 2010 were used.

Results

The single ACF occur in the youngest individuals (ACF < 5). Since the age of 38 years, the number of ACF gradually increases to show a decreasing tendency since the age of 60 years. The number of 5 < ACF < 10 occurs slightly later, since the age of 50 years, and dynamically increases reaching the maximum at the age of 62 years, subsequently the increase is proportional. ACF > 10 occur at a more advanced age (55 years) and their number gradually increases with age. The maximum number is observed at the age of 77 years.
In individuals not using high-fibre diets and with high intake of red meat, the probability of higher numbers of ACF increases. The probability of higher numbers of ACF (5 < ACF10) was observed in patients with colon diverticula. In patients with higher BMI, the number of ACF is higher.

Conclusion

Age significantly affects the number of colorectal ACF. The types of foods consumed can considerably increase the risk of colorectal ACF, which is particularly visible in individuals who do not regularly use high-fibre diets, those obese and with colon diverticula.
Literature
1.
go back to reference Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37(2):147–51.CrossRefPubMed Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett. 1987;37(2):147–51.CrossRefPubMed
2.
go back to reference Boyle P, Boffetta P, Autier P. Diet, nutrition and cancer: public, media and scientific confusion. Ann Oncol. 2008;19(10):1665–7.CrossRefPubMed Boyle P, Boffetta P, Autier P. Diet, nutrition and cancer: public, media and scientific confusion. Ann Oncol. 2008;19(10):1665–7.CrossRefPubMed
3.
go back to reference Krasuska ME. Rola odżywiania w profilaktyce onkologicznej. Zdrow Publiczne. 2006;116(2):296–300. Krasuska ME. Rola odżywiania w profilaktyce onkologicznej. Zdrow Publiczne. 2006;116(2):296–300.
5.
go back to reference Kardasz M, Pawłowska D Rola składników odżywczych oraz innych substancji 112. w powstawaniu nowotworów Borgis - Nowa Medycyna 2008;2:7–14. Kardasz M, Pawłowska D Rola składników odżywczych oraz innych substancji 112. w powstawaniu nowotworów Borgis - Nowa Medycyna 2008;2:7–14.
6.
go back to reference Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries with special reference to dietary practices. Int J Cancer. 1975;15:617–31.CrossRefPubMed
7.
go back to reference Prentice RL, Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from apractical reduction in fat consumption. Cancer Causes Control. 1990;1:81–7.CrossRefPubMed Prentice RL, Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from apractical reduction in fat consumption. Cancer Causes Control. 1990;1:81–7.CrossRefPubMed
8.
go back to reference McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687–95.PubMed McKeown-Eyssen G. Epidemiology of colorectal cancer revisited: are serum triglycerides and/or plasma glucose associated with risk? Cancer Epidemiol Biomarkers Prev. 1994;3:687–95.PubMed
9.
go back to reference Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin N Am. 2002;31:925–43.CrossRef Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin N Am. 2002;31:925–43.CrossRef
10.
go back to reference Evans RC, Fear S, Ashby D, et al. Diet and colorectal cancer: aninvestigation of lectin/galactose hypothesis. Gastroenterology. 2002;122:1784–92.CrossRefPubMed Evans RC, Fear S, Ashby D, et al. Diet and colorectal cancer: aninvestigation of lectin/galactose hypothesis. Gastroenterology. 2002;122:1784–92.CrossRefPubMed
11.
go back to reference De Kok TM, Van Fassen A, Glinghammar B, et al. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas. Dig Dis Sci. 2000;44:2218–25.CrossRef De Kok TM, Van Fassen A, Glinghammar B, et al. Bile acid concentrations, cytotoxicity, and pH of fecal water from patients with colorectal adenomas. Dig Dis Sci. 2000;44:2218–25.CrossRef
12.
go back to reference Lipkin M, Reddy B, Newmark H, et al. Dietary factors in human colorectal cancer. Annu Rev Nutr. 1999;19:545–86.CrossRefPubMed Lipkin M, Reddy B, Newmark H, et al. Dietary factors in human colorectal cancer. Annu Rev Nutr. 1999;19:545–86.CrossRefPubMed
13.
go back to reference Norat T, Łukanowa A, Ferrari P, et al. Meat consumption and colorectal cancer risk:dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98(2):241–56.CrossRefPubMed Norat T, Łukanowa A, Ferrari P, et al. Meat consumption and colorectal cancer risk:dose-response meta-analysis of epidemiological studies. Int J Cancer. 2002;98(2):241–56.CrossRefPubMed
14.
go back to reference Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines , meat intake and association with colon cancer in a population-based study. Am J Epidemiol. 2003;157:434–45.CrossRefPubMed Butler LM, Sinha R, Millikan RC, et al. Heterocyclic amines , meat intake and association with colon cancer in a population-based study. Am J Epidemiol. 2003;157:434–45.CrossRefPubMed
15.
go back to reference Reddy BS. Dietary fat and its relationship to large bowel cancer. Cancer Res. 1981;41:3700–5.PubMed Reddy BS. Dietary fat and its relationship to large bowel cancer. Cancer Res. 1981;41:3700–5.PubMed
16.
go back to reference Sesink AL, Termont DS, Kleibeuker JH, et al. Red meat and colon cancer; the cytotoxic and hyperproliferative effect of dietary heme. Cancer Res. 1999;59:5704–9.PubMed Sesink AL, Termont DS, Kleibeuker JH, et al. Red meat and colon cancer; the cytotoxic and hyperproliferative effect of dietary heme. Cancer Res. 1999;59:5704–9.PubMed
17.
go back to reference Wurzelmann JI, Silver A, Schreinmachers DM, et al. Iron intake and risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 1996;5:503–7. Wurzelmann JI, Silver A, Schreinmachers DM, et al. Iron intake and risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 1996;5:503–7.
18.
go back to reference Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med. 1990;8(2):191–200.CrossRefPubMed Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med. 1990;8(2):191–200.CrossRefPubMed
19.
go back to reference Rosenberg DW, Kappas A. Actions of orally administered organotin compounds on heme metabolism and cytochrome P-450 content and function in intestinal epithelium. Biochem Pharmacol. 1989;38:1155–61.CrossRefPubMed Rosenberg DW, Kappas A. Actions of orally administered organotin compounds on heme metabolism and cytochrome P-450 content and function in intestinal epithelium. Biochem Pharmacol. 1989;38:1155–61.CrossRefPubMed
20.
go back to reference Kowalczyk M, Siermontowski P, Mucha D, et al. Chromoendoscopy with a standard-resolution Colonoscope for evaluation of rectal aberrant crypt foci. PLoS One. 2016;11(2):e0148286.CrossRefPubMedPubMedCentral Kowalczyk M, Siermontowski P, Mucha D, et al. Chromoendoscopy with a standard-resolution Colonoscope for evaluation of rectal aberrant crypt foci. PLoS One. 2016;11(2):e0148286.CrossRefPubMedPubMedCentral
21.
go back to reference Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.CrossRefPubMed Takayama T, Katsuki S, Takahashi Y, et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med. 1998;339:1277–84.CrossRefPubMed
22.
go back to reference Shpitz B, Bomstein Y, Mekori Y, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol. 1998;29:469–75.CrossRefPubMed Shpitz B, Bomstein Y, Mekori Y, et al. Aberrant crypt foci in human colons: distribution and histomorphologic characteristics. Hum Pathol. 1998;29:469–75.CrossRefPubMed
23.
go back to reference Rudolph RE, Dominitz JA, Lampe JW, et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev. 2005;14:605–8.CrossRefPubMed Rudolph RE, Dominitz JA, Lampe JW, et al. Risk factors for colorectal cancer in relation to number and size of aberrant crypt foci in humans. Cancer Epidemiol Biomarkers Prev. 2005;14:605–8.CrossRefPubMed
24.
go back to reference Stevens RG, Swede H, Heinen CD, et al. Aberrant crypt foci in patents with a positive family history of sporadic colorectal cancer. Cancer Lett. 2006;248(2):262–8.CrossRefPubMed Stevens RG, Swede H, Heinen CD, et al. Aberrant crypt foci in patents with a positive family history of sporadic colorectal cancer. Cancer Lett. 2006;248(2):262–8.CrossRefPubMed
25.
go back to reference Maxon D, Raza M, Kenney R, et al. Aging et tabacco use are linked to the development of aberrant crypt foci (a predominately African-American population). Clin Gastroenterol Hepatol. 2005;3:271–8.CrossRef Maxon D, Raza M, Kenney R, et al. Aging et tabacco use are linked to the development of aberrant crypt foci (a predominately African-American population). Clin Gastroenterol Hepatol. 2005;3:271–8.CrossRef
27.
go back to reference Nascimbeni R, Villanacci V, Mariani PP, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol. 1999;23:1256–63.CrossRefPubMed Nascimbeni R, Villanacci V, Mariani PP, et al. Aberrant crypt foci in the human colon: frequency and histologic patterns in patients with colorectal cancer or diverticular disease. Am J Surg Pathol. 1999;23:1256–63.CrossRefPubMed
28.
go back to reference Roncucci L, Stamp D, Medline AA, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22:287–94.CrossRefPubMed Roncucci L, Stamp D, Medline AA, et al. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol. 1991;22:287–94.CrossRefPubMed
29.
go back to reference Hurlston DP, Karajeh M, Sanders DS, et al. Ractal aberrant crypt foci identified using high-magnification-chromoscopiccolonoscopy:biomarkers for flat and depressed neoplasia. Am J Gastroenterol. 2005;100:1283–9.CrossRef Hurlston DP, Karajeh M, Sanders DS, et al. Ractal aberrant crypt foci identified using high-magnification-chromoscopiccolonoscopy:biomarkers for flat and depressed neoplasia. Am J Gastroenterol. 2005;100:1283–9.CrossRef
30.
go back to reference Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.CrossRefPubMed Adler DG, Gostout CJ, Sorbi D, et al. Endoscopic identification and quantification of aberrant crypt foci in the human colon. Gastrointest Endosc. 2002;56:657–62.CrossRefPubMed
31.
go back to reference Stevens RG, Swede H, Rosenberg DW. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 2007;252:171–83.CrossRefPubMed Stevens RG, Swede H, Rosenberg DW. Epidemiology of colonic aberrant crypt foci: review and analysis of existing studies. Cancer Lett. 2007;252:171–83.CrossRefPubMed
32.
go back to reference Seike K, Koda K, Oda K, et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasm. Am J Gastroenterol. 2006;101:1362–9.CrossRefPubMed Seike K, Koda K, Oda K, et al. Assessment of rectal aberrant crypt foci by standard chromoscopy and its predictive value for colonic advanced neoplasm. Am J Gastroenterol. 2006;101:1362–9.CrossRefPubMed
33.
go back to reference Figueiredo P, Donato M, Urbano M, et al. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization. Int J Color Dis. 2009;24(4):441–50.CrossRef Figueiredo P, Donato M, Urbano M, et al. Aberrant crypt foci: endoscopic assessment and cell kinetics characterization. Int J Color Dis. 2009;24(4):441–50.CrossRef
34.
go back to reference Bruce WR, Garcia A. Medline a possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomark Prev. 2000;9:1271–9. Bruce WR, Garcia A. Medline a possible mechanisms relating diet and risk of colon cancer. Cancer Epidemiol Biomark Prev. 2000;9:1271–9.
35.
go back to reference Tuominen I, Al-Rabadi L, Stavrakis D, et al. Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice. PLoS One. 2013;8(4):e60939.CrossRefPubMedPubMedCentral Tuominen I, Al-Rabadi L, Stavrakis D, et al. Diet-induced obesity promotes colon tumor development in azoxymethane-treated mice. PLoS One. 2013;8(4):e60939.CrossRefPubMedPubMedCentral
36.
go back to reference Olivo-Marston SE, Hursting SD, Perkins SN, et al. Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression. PLoS One. 2014;9(4):e94765.CrossRefPubMedPubMedCentral Olivo-Marston SE, Hursting SD, Perkins SN, et al. Effects of calorie restriction and diet-induced obesity on murine colon carcinogenesis, growth and inflammatory factors, and microRNA expression. PLoS One. 2014;9(4):e94765.CrossRefPubMedPubMedCentral
37.
go back to reference Takahashi H, Yoneda K, Tomimoto A, et al. Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment. J Pharmacol Sci. 2007;105:129–32.CrossRefPubMed Takahashi H, Yoneda K, Tomimoto A, et al. Life style-related diseases of the digestive system: colorectal cancer as a life style-related disease: from carcinogenesis to medical treatment. J Pharmacol Sci. 2007;105:129–32.CrossRefPubMed
38.
go back to reference Stattin P, Lukanowa A, Biessy C. Obesity and colon cancer: does leptin provide a link? Int J Cancer. 2004;109:149–52.CrossRefPubMed Stattin P, Lukanowa A, Biessy C. Obesity and colon cancer: does leptin provide a link? Int J Cancer. 2004;109:149–52.CrossRefPubMed
39.
go back to reference Giovancucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity and risk colon cancer and adenoma in men. Ann Intern Med. 1995;122(5):327–34.CrossRef Giovancucci E, Ascherio A, Rimm EB, et al. Physical activity, obesity and risk colon cancer and adenoma in men. Ann Intern Med. 1995;122(5):327–34.CrossRef
40.
go back to reference Vaccina F, Scorcioni F, Pedroni M, et al. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa. Anticancer Res. 1998;18:3451–6.PubMed Vaccina F, Scorcioni F, Pedroni M, et al. Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa. Anticancer Res. 1998;18:3451–6.PubMed
41.
go back to reference Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables and colon cancer: critical revive and meta-analyses of the epidemiological evidence. J Natl Cancer Inst. 1990;82:650–61.CrossRefPubMed Trock B, Lanza E, Greenwald P. Dietary fiber, vegetables and colon cancer: critical revive and meta-analyses of the epidemiological evidence. J Natl Cancer Inst. 1990;82:650–61.CrossRefPubMed
42.
go back to reference Howe GR, Benito E, Castelleto R, et al. Dietary intake of fiber and decreased risk of cancer of colon and rectum:evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst. 1992;84:1887–96.CrossRefPubMed Howe GR, Benito E, Castelleto R, et al. Dietary intake of fiber and decreased risk of cancer of colon and rectum:evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst. 1992;84:1887–96.CrossRefPubMed
43.
go back to reference Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology. 1997;113:1992–8.CrossRefPubMed Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: evolving concepts of their chemopreventive actions. Gastroenterology. 1997;113:1992–8.CrossRefPubMed
45.
go back to reference Potter JD, Slattery ML, Bostick RM, et al. Colon Cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545.CrossRefPubMed Potter JD, Slattery ML, Bostick RM, et al. Colon Cancer: a review of the epidemiology. Epidemiol Rev. 1993;15:499–545.CrossRefPubMed
46.
go back to reference Swede H, Rohan TE, Yu H, et al. Number of aberrant crypt foci associated adiposity and IGF1 bioavailability. Cancer Causes Control. 2009;20(5):653–61.CrossRefPubMed Swede H, Rohan TE, Yu H, et al. Number of aberrant crypt foci associated adiposity and IGF1 bioavailability. Cancer Causes Control. 2009;20(5):653–61.CrossRefPubMed
47.
go back to reference Dolara P, Caderni G, Lancioni L, et al. Aberrant crypt foci in human colon carcinogenesis. Cancer Detect Prev. 1997;21:135–40.PubMed Dolara P, Caderni G, Lancioni L, et al. Aberrant crypt foci in human colon carcinogenesis. Cancer Detect Prev. 1997;21:135–40.PubMed
48.
go back to reference Yokota T, Sugano K, Kondo H, et al. Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc. 1997;46:61–5.CrossRefPubMed Yokota T, Sugano K, Kondo H, et al. Detection of aberrant crypt foci by magnifying colonoscopy. Gastrointest Endosc. 1997;46:61–5.CrossRefPubMed
Metadata
Title
Occurrence of colorectal aberrant crypt foci depending on age and dietary patterns of patients
Authors
Marek Kowalczyk
Marcin Orłowski
Piotr Siermontowski
Dariusz Mucha
Krzysztof Zinkiewicz
Waldemar Kurpiewski
Ewa Zieliński
Iwona Kowalczyk
Agnieszka Pedrycz
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-4100-8

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine